Harmony Biosciences Holdings, Inc. (HRMY)

39.82 -1.44 (-3.49%) USD  |  NASDAQ  |  Sep 28, 15:06
More

Harmony Biosciences Holdings Cash from Operations (Annual) : 348.20M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for HRMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 348.20M
December 31, 2024 219.82M
December 31, 2023 219.39M
December 31, 2022 144.47M
Date Value
December 31, 2021 98.56M
December 31, 2020 -2.985M
December 31, 2019 -75.44M
December 31, 2018 -38.80M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Liquidia Corp. -35.69M
Pfizer Inc. 11.70B
Bristol Myers Squibb Co. 14.16B
Repligen Corp. 117.42M
Johnson & Johnson 24.53B